MedChemExpress Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity.

Pris og tilgængelighed
Tekniske data

Kemisk navn eller materiale	Falnidamol
Sundhedsfare 1	H302∣H315∣H319∣H335
Formel vægt	387.84
Opløselighedsinformation	DMSO : 31.25 mg/mL (80.57 mM; ultrasonic and warming and heat to 60°C)
Procent renhed	97.03%
Fysisk form	Solid
Farve	Brownish Yellow
Grad	Research
Anbefalet opbevaring	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Molekylvægt (g/mol)	387.84
CAS	196612-93-8
Synonym	BIBX 1382
Holdbarhed	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
SMIL	ClC1=CC(NC2=NC=NC3=CN=C(NC(CC4)CCN4C)N=C23)=CC=C1F
Renhedsgrad noter	Research
Molekylær formel	C₁₈H₁₉ClFN₇
Til brug med (applikation)	Cancer-Kinase/protease

CAS RN 196612-93-8

Filtrerede søgeresultater

Snævre resultater